Epidemiology of Merkel Carcinomas in the Bas-Rhin
- Conditions
- Merkel Carcinoma
- Registration Number
- NCT03518307
- Lead Sponsor
- University Hospital, Strasbourg, France
- Brief Summary
The aim of this work is to study demographic, clinical, management (diagnostic and therapeutic) and survival data concerning patients with Merkel's carcinoma in the Lower Rhine, thus obtaining the first French data.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- Age >18 years
- Diagnosis of primary Merkel carcinoma (topographic code C44 morphological code 8247/3)
- Diagnosis made between 1983 and 2011
- Patient residing in the Bas-Rhin at the date of diagnosis
- Patient who has given his consent for the use of his data for research purposes
Exclusion Criteria
- Refusal to participate in research
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Retrospective study of demographic, clinical, management (diagnostic and therapeutic) and survival data for patients with Merkel carcinoma in the Lower Rhine region The period from from January 1st, 1983 to December 31st, 2011 will be examined
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Merkel Cell Carcinoma incidence trends in the Bas-Rhin Cancer Registry?
How do demographic factors in NCT03518307 compare to global Merkel Cell Carcinoma epidemiology?
What prognostic biomarkers correlate with survival outcomes in the Bas-Rhin Merkel Carcinoma study?
What adverse events are reported with standard therapies for Merkel Cell Carcinoma in the Bas-Rhin registry?
How does the Bas-Rhin Merkel Carcinoma study inform current therapeutic strategies and future drug development?
Trial Locations
- Locations (1)
Service de Dermatologie
🇫🇷Strasbourg, France
Service de Dermatologie🇫🇷Strasbourg, FranceDan LIPSKER, MD, PhDPrincipal InvestigatorAlice Kieny, MDSub Investigator